Allianz Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $531K | Buy |
12,300
+4,500
| +58% | +$194K | ﹤0.01% | 1385 |
|
|
2025
Q1 | $270K | Buy |
+7,800
| New | +$270K | ﹤0.01% | 1596 |
|
|
2023
Q2 | – | Sell |
-21,100
| Closed | -$350K | – | 1669 |
|
|
2023
Q1 | $350K | Buy |
+21,100
| New | +$350K | ﹤0.01% | 1483 |
|
|
2022
Q1 | – | Sell |
-33,228
| Closed | -$554K | – | 1869 |
|
|
2021
Q4 | $554K | Sell |
33,228
-8,130
| -20% | -$136K | ﹤0.01% | 1792 |
|
|
2021
Q3 | $1.94M | Sell |
41,358
-2,900
| -7% | -$136K | ﹤0.01% | 1384 |
|
|
2021
Q2 | $2.7M | Sell |
44,258
-13,860
| -24% | -$845K | ﹤0.01% | 1222 |
|
|
2021
Q1 | $3.58M | Buy |
58,118
+29,658
| +104% | +$1.83M | ﹤0.01% | 1095 |
|
|
2020
Q4 | $2.02M | Hold |
28,460
| – | – | ﹤0.01% | 1293 |
|
|
2020
Q3 | $1.07M | Sell |
28,460
-2,550
| -8% | -$95.7K | ﹤0.01% | 1394 |
|
|
2020
Q2 | $1.01M | Sell |
31,010
-24,749
| -44% | -$807K | ﹤0.01% | 1419 |
|
|
2020
Q1 | $1.62M | Sell |
55,759
-25,337
| -31% | -$735K | ﹤0.01% | 1302 |
|
|
2019
Q4 | $2.84M | Buy |
+81,096
| New | +$2.84M | ﹤0.01% | 1358 |
|